Literature DB >> 760390

Verapamil and nifedipine inhibition of contractions induced by potassium and noradrenaline in human mesenteric arteries and veins.

E Mikkelsen, K E Andersson, O Lederballe Pedersen.   

Abstract

Ring preparations of human mesenteric arteries and veins were contracted by noradrenaline (1.8 x 10(-5)M) or potassium (127mM). Isometric tension was recorded. In the arterial preparations, the maximum response to noradrenaline was 97 +/- 8% (mean +/- S.E.M.) of that to potassium. In the veins, the corresponding figure was 38 +/- 4%. The calcium antagonists verapamil (2.2 x 10(-7)-2.2 x 10(-5)M) and nifedipine (2.9 x 10(-8)-2.9 x 10(-6)M) relaxed both arteries and veins contracted by noradrenaline or potassium, and reduced the responses to these agents when added 15 min. before stimulation. The time course of relaxation of potassium contracted preparations, induced by verapamil and nifedipine, was more rapid and complete than that produced by a calcium-free, high potassium solution. In contrast to verapamil, nifedipine caused a more pronounced inhibition of the potassium than of the noradrenaline evoked contractions in both arteries and veins. After exposure to a calcium-free medium for 30 min., the arterial response to noradrenaline was significantly (P less than 0.05) greater than that to potassium. However, the reverse was found in the veins. In both types of vessel, verapamil (2.2 x 10(-6)M) and nifedipine (2.9--10(-7)M) were equi-effective in reducing the noradrenaline reactivity, not only between mesenteric arteries and veins, but also between, e.g. peripheral and mesenteric vessels. The calcium antagonists nifedipine and verapamil do not have an identical mode of action. However, both agents seem to inhibit influx of extracellular calcium, and might also have an inhibitory effect on the release of intracellular calcium.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760390     DOI: 10.1111/j.1600-0773.1979.tb02304.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  14 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Blockade of slow calcium channels and regulation of circulatory pressor responses in uncomplicated hypertension.

Authors:  B Silke; R C Ahuja; R C Okoli; G I Nelson; S H Taylor
Journal:  Ir J Med Sci       Date:  1983-10       Impact factor: 1.568

3.  Acute and chronic effects of nifedipine in arterial hypertension.

Authors:  O L Pedersen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

4.  Vasodilatory effect of nicardipine and verapamil in the forearm of hypertensive as compared with normotensive man.

Authors:  U L Hulthén; P Bolli; F R Bühler
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Anti-hypertensive dose-response effects of nicardipine in stable essential hypertension.

Authors:  S H Taylor; M A Frais; P Lee; S P Verma; N Jackson; B Silke
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

6.  Influence of extracellular calcium and calcium antagonists on contractions induced by potassium and prostaglandin F2 alpha in isolated cerebral and mesenteric arteries of the cat.

Authors:  K E Andersson; L Edvinsson; E T MacKenzie; T Skärby; A R Young
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

7.  The effect of nifedipine and verapamil on KC1-induced rhythmic contractions of guinea pig ureter in vitro.

Authors:  C A Maggi; A Meli
Journal:  Experientia       Date:  1984-07-15

8.  Inhibitory effects of glyceryl trinitrate on alpha-adrenoceptor mediated contraction in the human internal mammary artery.

Authors:  G W He; J Shaw; C Q Yang; C Hughes; D Thomson; B McCaughan; P N Hendle; D K Baird
Journal:  Br J Clin Pharmacol       Date:  1992-09       Impact factor: 4.335

9.  Differential effects of nifedipine, verapamil, and diltiazem on noradrenaline-induced contractions, adrenergic transmitter release, and alpha-adrenoceptor binding in the female rabbit urethra.

Authors:  B Larsson; E D Högestätt; A Mattiasson; K E Andersson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

10.  Comparative studies on the effects of tolmesoxide (Rx71107), a tolmesoxide metabolite (Rx71112) and nifedipine in isolated blood vessels.

Authors:  E Mikkelsen; O L Pedersen
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.